Evans syndrome during pembrolizumab therapy for upper urinary tract cancer

Evans syndrome during pembrolizumab therapy for upper urinary tract cancer

Introduction Immune checkpoint inhibitors are available for the treatment of advanced urothelial carcinoma; however, serious adverse events occasionally occur. Here, we report a rare case of Evans syndrome attributed to the use of an immune checkpoint inhibitor. Case presentation A 56‐year‐old man w...

Full description

Bibliographic Details
Main Authors: Shota Kakita, Tomohiro Matsuo, Masaharu Ohki, Ayaka Tsuchiyama, Takuji Yasuda, Hiromi Nakanishi, Kensuke Mitsunari, Kojiro Ohba, Ryoichi Imamura
Format: Article
Language:English
Published: Wiley 2023-09-01
Series:IJU Case Reports
Subjects:
autoimmune hemolytic anemia
Evans syndrome
immune checkpoint inhibitor
immune thrombocytopenic purpura
immune‐related adverse event
Online Access:https://doi.org/10.1002/iju5.12609

Internet

https://doi.org/10.1002/iju5.12609

Similar Items